Skip to main content
Clinical Trials/ACTRN12621001526864
ACTRN12621001526864
Recruiting
未知

Standardised Treatment And Monitoring Protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study)

Western Sydney Local Health District0 sites50 target enrollmentNovember 10, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Bacterial infections
Sponsor
Western Sydney Local Health District
Enrollment
50
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2021
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patient for whom at least two suitably qualified clinical specialists have agreed phage therapy should be used
  • 2\) A suitable phage(s) product is available that complies with all relevant regulatory requirements for therapeutic administration

Exclusion Criteria

  • Participant, parent or guardian or person responsible has not provided informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials